Updating the landscape of direct-to-consumer pharmacogenomic testing

Pharmacogenomics has identified important drug–gene interactions that affect the safety and efficacy of medications. Direct-to-consumer genetic testing, when first introduced, included some pharmacogenomic-related genes. The current landscape of pharmacogenomic direct-to-consumer testing is reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales: Filipski, Kelly K, Murphy, John D, Helzlsouer, Kathy J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572950/
https://www.ncbi.nlm.nih.gov/pubmed/28860839
http://dx.doi.org/10.2147/PGPM.S140461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572950/
https://www.ncbi.nlm.nih.gov/pubmed/28860839
http://dx.doi.org/10.2147/PGPM.S140461

Ejemplares similares